Lymphoma, Mantle-Cell

"Lymphoma, Mantle-Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A form of non-Hodgkin lymphoma having a usually diffuse pattern with both small and medium lymphocytes and small cleaved cells. It accounts for about 5% of adult non-Hodgkin lymphomas in the United States and Europe. The majority of mantle-cell lymphomas are associated with a t(11;14) translocation resulting in overexpression of the CYCLIN D1 gene (GENES, BCL-1).

Descriptor ID	D020522
MeSH Number(s)	C04.557.386.480.525 C15.604.515.569.480.525 C20.683.515.761.480.525
Concept/Terms	Lymphoma, Mantle-Cell Lymphoma, Mantle-Cell Lymphoma, Mantle Cell Lymphomas, Mantle-Cell Mantle-Cell Lymphomas Lymphocytic Lymphoma, Diffuse, Poorly Differentiated Lymphocytic Lymphoma, Diffuse, Poorly-Differentiated Mantle-Zone Lymphoma Lymphoma, Mantle-Zone Lymphomas, Mantle-Zone Mantle Zone Lymphoma Mantle-Zone Lymphomas Lymphoma, Lymphocytic, Diffuse, Intermediate Differentiated Lymphoma, Lymphocytic, Diffuse, Poorly-Differentiated Lymphoma, Small-Cell, Centrocytic Mantle-Cell Lymphoma Mantle Cell Lymphoma Diffuse Lymphocytic Lymphoma, Poorly-Differentiated Diffuse Lymphocytic Lymphoma, Poorly Differentiated Lymphoma, Centrocytic Small-Cell Centrocytic Small-Cell Lymphoma Centrocytic Small-Cell Lymphomas Lymphoma, Centrocytic Small Cell Lymphomas, Centrocytic Small-Cell Small-Cell Lymphoma, Centrocytic Small-Cell Lymphomas, Centrocytic Lymphoma, Lymphocytic, Intermediate Lymphoma, Lymphocytic, Intermediate

Below are MeSH descriptors whose meaning is more general than "Lymphoma, Mantle-Cell".

Diseases [C]
Neoplasms [C04]
Neoplasms by Histologic Type [C04.557]
Lymphoma [C04.557.386]
Lymphoma, Non-Hodgkin [C04.557.386.480]
Lymphoma, Mantle-Cell [C04.557.386.480.525]
Hemic and Lymphatic Diseases [C15]
Lymphatic Diseases [C15.604]
Lymphoproliferative Disorders [C15.604.515]
Lymphoma [C15.604.515.569]
Lymphoma, Non-Hodgkin [C15.604.515.569.480]
Lymphoma, Mantle-Cell [C15.604.515.569.480.525]
Immune System Diseases [C20]
Immunoproliferative Disorders [C20.683]
Lymphoproliferative Disorders [C20.683.515]
Lymphoma [C20.683.515.761]
Lymphoma, Non-Hodgkin [C20.683.515.761.480]
Lymphoma, Mantle-Cell [C20.683.515.761.480.525]

Below are MeSH descriptors whose meaning is related to "Lymphoma, Mantle-Cell".

Below are MeSH descriptors whose meaning is more specific than "Lymphoma, Mantle-Cell".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Lymphoma, Mantle-Cell" by people in this website by year, and whether "Lymphoma, Mantle-Cell" was a major or minor topic of these publications.

Bar chart showing 10 publications over 9 distinct years, with a maximum of 2 publications in 2014

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2004	1	0	1
2008	0	1	1
2011	1	0	1
2013	1	0	1
2014	2	0	2
2015	1	0	1
2020	1	0	1
2022	1	0	1
2023	1	0	1

Below are the most recent publications written about "Lymphoma, Mantle-Cell" by people in Profiles.

Arun Kumar S, Gao J, Patel SA. The shifting therapeutic paradigm for relapsed/refractory mantle cell lymphoma. Leuk Res. 2023 11; 134:107385.

View in: PubMed
Rhee J, Birmann BM, De Roos AJ, Epstein MM, Martinez-Maza O, Breen EC, Magpantay LI, Levin LI, Visvanathan K, Hosgood HD, Rohan TE, Smoller SW, Bassig BA, Qi L, Shu XO, Koh WP, Zheng W, Yuan JM, Weinstein SJ, Albanes D, Lan Q, Rothman N, Purdue MP. Circulating immune markers and risks of non-Hodgkin lymphoma subtypes: A pooled analysis. Int J Cancer. 2023 Mar 01; 152(5):865-878.

View in: PubMed
Swenson SA, Gilbreath TJ, Vahle H, Hynes-Smith RW, Graham JH, Law HC, Amador C, Woods NT, Green MR, Buckley SM. UBR5 HECT domain mutations identified in mantle cell lymphoma control maturation of B cells. Blood. 2020 07 16; 136(3):299-312.

View in: PubMed
Sahu KK, Mahagaokar K, Patel B, Winokur D, Suzuki S, Daly JS, Ramanathan M, Cerny J. Strongyloides stercoralis hyperinfection syndrome in mantle cell lymphoma in post-transplant setting. Ann Hematol. 2021 Apr; 100(4):1089-1091.

View in: PubMed
Wang JD, Katz SG, Morgan EA, Yang DT, Pan X, Xu ML. Proapoptotic protein BIM as a novel prognostic marker in mantle cell lymphoma. Hum Pathol. 2019 11; 93:54-64.

View in: PubMed
Myklebust JH, Brody J, Kohrt HE, Kolstad A, Czerwinski DK, W?lchli S, Green MR, Tr?en G, Liest?l K, Beiske K, Houot R, Delabie J, Alizadeh AA, Irish JM, Levy R. Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling. Blood. 2017 02 09; 129(6):759-770.

View in: PubMed
Lui JK, Gillespie W, Gaudet R, Brettler DB. Occam's Razor and the Diagnosis of Mantle Cell Lymphoma. Am J Med. 2015 Dec; 128(12):e25-6.

View in: PubMed
Pherson M, Yon JR, Wilhelm S, Toscano MP, Kruse EJ. Mantle cell lymphoma metastasis to the gallbladder. Am Surg. 2014 Jul; 80(7):e198-9.

View in: PubMed
Phelps A, Elaba Z, Murphy MJ. Blastoid mantle cell lymphoma with cutaneous involvement and aberrant immunophenotype. Am J Dermatopathol. 2014 Jun; 36(6):526-7.

View in: PubMed
Phelps A, Gorgan M, Elaba Z, Pennington M, Norwood C, Rezuke W, Murphy MJ. CD10-positive blastoid mantle cell lymphoma with secondary cutaneous involvement. J Cutan Pathol. 2013 Aug; 40(8):765-7.

View in: PubMed

People

Explore

Similar Concepts

Top Journals